CN101991723B - A kind of Shiqi exogenous Chinese medicine oral liquid - Google Patents

A kind of Shiqi exogenous Chinese medicine oral liquid Download PDF

Info

Publication number
CN101991723B
CN101991723B CN201010547777A CN201010547777A CN101991723B CN 101991723 B CN101991723 B CN 101991723B CN 201010547777 A CN201010547777 A CN 201010547777A CN 201010547777 A CN201010547777 A CN 201010547777A CN 101991723 B CN101991723 B CN 101991723B
Authority
CN
China
Prior art keywords
chinese medicine
oral liquid
traditional chinese
pandanus
jasmine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201010547777A
Other languages
Chinese (zh)
Other versions
CN101991723A (en
Inventor
赖智填
王凤严
苏观凤
陈锦琼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongshan Zhongzhi Pharmaceutical Group Co ltd
Original Assignee
Zhongshan Zhongzhi Pharmaceutical Group Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Zhongzhi Pharmaceutical Group Co ltd filed Critical Zhongshan Zhongzhi Pharmaceutical Group Co ltd
Priority to CN201010547777A priority Critical patent/CN101991723B/en
Publication of CN101991723A publication Critical patent/CN101991723A/en
Priority to HK11107207.1A priority patent/HK1153132B/en
Application granted granted Critical
Publication of CN101991723B publication Critical patent/CN101991723B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine oral liquid, in particular to a traditional Chinese medicine oral liquid for treating and preventing influenza. The oral liquid is prepared by processing the following traditional Chinese medicine raw materials and a pharmaceutically acceptable carrier: 980g of roughhaired holly 245, 980g of berchemia lineata 245, 980g of syzygium jambos 245, 98-392g of clerodendrum odoratum and 980g of radix seu folium Rubiae Craifolii 245.

Description

一种石歧外感中药口服液A kind of Shiqi exogenous Chinese medicine oral liquid

技术领域 technical field

本发明属于中药学领域,涉及一种中药口服液,具体涉及一种治疗和预防流行性感冒的中药口服液及其制备方法。The invention belongs to the field of traditional Chinese medicine and relates to a traditional Chinese medicine oral liquid, in particular to a traditional Chinese medicine oral liquid for treating and preventing influenza and a preparation method thereof.

背景技术 Background technique

感冒及流行性感冒都是由病毒感染引起的。由于病毒是经由空气传播,因此首当其冲的是鼻子。病毒首先感染鼻黏膜,然后不断繁殖,引致鼻黏膜发炎,出现打喷嚏、流鼻涕、鼻塞等病症。一般的感冒是指鼻感冒,对人体的影响通常只限于呼吸系统。所有症状都与鼻有关,如鼻涕、鼻塞和喉咙痛、咳嗽、甚至发烧等。一般数天后便可痊愈。流行性感冒是由流感病毒引致。流感症状影响全身,包括发热发冷、出汗、全身酸痛、头痛、骨痛、肌肉痛、疲倦乏力、食欲不振、咳嗽、鼻塞等,严重时会引起肺炎及其他并发症,可以致命。流感病毒的特性是有多种类型,每十年左右便会出现新的病毒品种。Both colds and influenza are caused by viral infections. Since the virus is airborne, it is the nose that bears the brunt. The virus first infects the nasal mucosa and then multiplies continuously, causing inflammation of the nasal mucosa and symptoms such as sneezing, runny nose, and nasal congestion. A common cold refers to a nasal cold, which generally affects the human body only on the respiratory system. All symptoms are related to the nose, such as runny nose, stuffy nose and sore throat, cough, and even fever. It usually heals in a few days. Influenza is caused by influenza virus. Influenza symptoms affect the whole body, including fever and chills, sweating, body aches, headache, bone pain, muscle pain, fatigue, loss of appetite, cough, nasal congestion, etc. In severe cases, it can cause pneumonia and other complications, which can be fatal. The nature of influenza viruses is that there are many types, and new virus strains appear every ten years or so.

中医学上并没有病毒这个概念,对于流感或感冒,一律统称为“外邪入侵”,因为病毒发源地不论是鼻黏膜或呼吸道,都属脏腑以外,因此称为“外邪”。中医按病症的表徵和身体反应分类,大致分“风寒感冒”和“风热感冒”。风热感冒症状:喉痛、发烧、没胃口、流鼻涕、有浓痰。风寒感冒症状:畏寒怕风、疲倦、流清鼻水、没有食欲。There is no concept of virus in Chinese medicine. For flu or colds, they are collectively referred to as "exogenous evil invasion". Because the origin of the virus, whether it is the nasal mucous membrane or the respiratory tract, is outside the viscera, it is called "exogenous evil". Traditional Chinese medicine is classified according to symptoms and physical reactions, and can be roughly divided into "wind-cold cold" and "wind-heat cold". Symptoms of anemopyretic cold: sore throat, fever, loss of appetite, runny nose, thick phlegm. Symptoms of anemofrigid and cold: chills and wind, fatigue, runny nose, loss of appetite.

石歧外感茶颗粒,标准编号:WS3-B 2672-97,处方:岗梅铁包金蒲桃臭屎茉莉露兜簕。功能与主治:疏风清热,解暑消食。用于外感引起的发热头痛,食滞饱胀,喉干舌燥,预防流行性感冒。用法与用量:开水冲服,一次10~20g,一日3次。规格:每袋装10g。发明人通过对现有技术的改进,制备一种治疗和预防流行性感冒的中药口服液。Shiqi external sensation tea granules, standard number: WS3-B 2672-97, prescription: Gangmei iron-wrapped golden apple peach stinky feces jasmine pandanus. Functions and indications: Dispelling wind and clearing heat, relieving summer heat and eliminating food. It is used for fever and headache caused by exogenous pathogenic factors, stagnation of food, fullness, dry throat, and prevention of influenza. Usage and dosage: Take after boiling water, 10-20g each time, 3 times a day. Specifications: 10g per bag. The inventor prepared a traditional Chinese medicine oral liquid for treating and preventing influenza by improving the prior art.

石歧外感茶颗粒的中药原料,其来源于:The traditional Chinese medicine raw materials of Shiqi Waigan tea granules are derived from:

露兜簕:露兜树Pandanus tectorius Sol.及其近缘种;Pandanus: Pandanus tectorius Sol. and its relatives;

铁包金:铁包金Berchemia lineate(Linn.)DC.、多花勾儿茶Berchemia floribunda(Wall.)Brongn.、光枝勾儿茶Berchemia polyphylla wall.ex Laws.Var.leiocladaHand.-Mazz.及其近缘种;Iron-clad gold: Iron-clad gold Berchemia lineate (Linn.) DC., Berchemia floribunda (Wall.) Brongn., Bechemia polyphylla wall.ex Laws.Var.leiocladaHand.-Mazz. and closely related species

蒲桃:蒲桃Syzygium jambos(Linn.)Alston及其近缘种;Rose apple: Rose apple Syzygium jambos (Linn.) Alston and its relatives;

岗梅:梅叶冬青Ilex asprella(Hook.et Arn.)Champ.ex Benth及其近缘种;Gangmei: Ilex asprella (Hook.et Arn.) Champ.ex Benth and its relatives;

臭屎茉莉:尖齿臭茉莉Clerodendrum lindleyi Decne.ex Planch.、重瓣臭茉莉Clerodendrum philippinum Schauer、臭茉莉Clerodendrum philippinum Schauer var.simplex Moldenke及其近缘种;Smelly jasmine: Clerodendrum lindleyi Decne.ex Planch., Clerodendrum philippinum Schauer, Clerodendrum philippinum Schauer var.simplex Moldenke and their relatives;

尽管石歧外感茶颗粒已经上市多年,但是患者对其效果并不满意,主要原因存在几点:其口感不好;服用不便,需要开水冲服;稳定性不好,贮存时间短;检测方法不准确,不能保证药品质量。另外,由于中药成分复杂,提取工艺相对落后,制备中易出现吸湿、流动性差、难崩解等常见问题,通过加入适宜的辅料,改进工艺,可提高中药的质量及疗效,并提高生产效率。Although Shiqi Waigan tea granule has been on the market for many years, patients are not satisfied with its effect. The main reasons are: its taste is not good; it is inconvenient to take, it needs to be taken with boiled water; the stability is not good, the storage time is short; the detection method is not accurate , cannot guarantee the quality of medicines. In addition, due to the complex ingredients of traditional Chinese medicine, the extraction process is relatively backward, and common problems such as moisture absorption, poor fluidity, and difficulty in disintegration are prone to occur during preparation. By adding appropriate excipients and improving the process, the quality and curative effect of traditional Chinese medicine can be improved, and production efficiency can be improved.

本发明的发明人根据中医理论,并且通过不断的科学实验,对配方和制备方法进行了筛选,有效的解决上了上述问题。According to the theory of traditional Chinese medicine, the inventor of the present invention screened the formula and preparation method through continuous scientific experiments, and effectively solved the above-mentioned problems.

发明内容 Contents of the invention

本发明的目的在于提供一种治疗和预防流行性感冒的中药口服液。The object of the present invention is to provide a kind of traditional Chinese medicine oral liquid for treating and preventing influenza.

本发明所述的中药口服液由以下中药原料药和药学上可接受的载体加工制成:Chinese medicine oral liquid of the present invention is processed by following Chinese medicine raw material and pharmaceutically acceptable carrier:

岗梅245-980g        铁包金245-980g    蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g

臭屎茉莉98-392g    露兜簕245-980gSmelly jasmine 98-392g Pandanus 245-980g

以上组成中,药的重量是以生药计算的,以重量作为配比,在生产时可按照比例增大或减少,如大规模生产可以以公斤为单位,或以吨为单位,小规模生产也可以以克或毫克为单位,重量可以增大或者减小,但各组成之间的生药材重量配比的比例不变。In the above composition, the weight of the medicine is calculated based on the crude drug, and the weight is used as the proportion, which can be increased or decreased according to the proportion during production. For example, the unit of kilogram or ton can be used for large-scale production, and the unit of small-scale production can also be The unit can be gram or milligram, and the weight can be increased or decreased, but the weight ratio of the raw medicinal materials among the components remains unchanged.

以上重量配比的比例是经过科学筛选得到的,对于特殊病人,如重症或轻症,肥胖或瘦小的病人,可以相应调整组成的量的配比,增加或减少不超过100%,药效不变。The proportion of the above weight ratio is obtained through scientific screening. For special patients, such as severe or mild, obese or thin patients, the proportion of the composition can be adjusted accordingly, and the increase or decrease does not exceed 100%. Change.

以上组成可以制成本发明的口服液1000ml。The above composition can be made into 1000ml of oral liquid of the present invention.

优选的,本发明所述的中药口服液由以下中药原料药和药学上可接受的载体加工制成:Preferably, the traditional Chinese medicine oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:

岗梅245-980g        铁包金245-980g    蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g

臭屎茉莉98-392g     露兜簕245-980g    矫味剂2-100gSmelly jasmine 98-392g Pandanus 245-980g Flavoring agent 2-100g

抑菌剂1-4g          增稠剂1.5-6g      蒸馏水10-1000mlBacteriostat 1-4g Thickener 1.5-6g Distilled water 10-1000ml

其中,所述抑菌剂包括但不仅限于山梨酸钾、苯酚、壳聚糖、101果汁澄清剂、ZTC1+1、乙醇等。Wherein, the bacteriostatic agent includes but not limited to potassium sorbate, phenol, chitosan, 101 fruit juice clarifier, ZTC1+1, ethanol and the like.

其中,所述矫味剂包括但不仅限于蔗糖、甘露醇、木糖醇、甜菊糖甙、乳糖、果糖、蔗糖、蛋白糖、麦芽糖醇、甘草甜素、环己氨基磺酸钠、明胶、阿斯巴甜、香蕉香精、菠萝香精、香兰素、香橙香精、桔子香精、薄荷香精、人参香精、枸椽酸、柠檬酸等,可单独使用,也可组合使用。Wherein, the flavoring agent includes but not limited to sucrose, mannitol, xylitol, steviol glycoside, lactose, fructose, sucrose, protein sugar, maltitol, glycyrrhizin, sodium cyclamate, gelatin, Spartame, banana flavor, pineapple flavor, vanillin, orange flavor, orange flavor, mint flavor, ginseng flavor, citric acid, citric acid, etc. can be used alone or in combination.

其中,所述增稠剂包括但不仅限于海藻酸钾、淀粉、果胶、琼脂、明胶、海藻脂、角叉胶、糊精、黄耆胶、多糖素衍生物。Wherein, the thickener includes but not limited to potassium alginate, starch, pectin, agar, gelatin, algae fat, carrageenan, dextrin, tragacanth gum, and polysaccharide derivatives.

进一步优选的,本发明所述的口服液由以下中药原料药和药学上可接受的载体加工制成:Further preferably, the oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:

岗梅245-980g       铁包金245-980g    蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g

臭屎茉莉98-392g    露兜簕245-980g    蔗糖2-100gSmelly jasmine 98-392g Pandanus 245-980g Sucrose 2-100g

山梨酸钾1-4g       海藻酸钾1.5-6g    蒸馏水10-1000ml。Potassium sorbate 1-4g Potassium alginate 1.5-6g Distilled water 10-1000ml.

更加优选的,本发明所述的口服液由以下中药原料药和药学上可接受的载体加工制成:More preferably, the oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g

山梨酸钾2g      海藻酸钾3g    蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.

本发明其他优选的配方组成在实施例中。Other preferred formulations of the present invention are included in the examples.

本发明的另一个目的在于提供本发明所述口服液的制备方法。Another object of the present invention is to provide the preparation method of the oral liquid of the present invention.

本发明所述的口服液的制备方法,包括以下步骤:The preparation method of oral liquid of the present invention comprises the following steps:

本发明的中药制剂,是通过将上述配方组成的中药原料经过提取或其他方式加工,取以上岗梅490g,铁包金490g,蒲桃490g,臭屎茉莉196g,露兜簕490g,加水煎煮二次,每次2小时,每次加水量为药材量的6倍,合并提取液,滤过,滤液浓缩稠膏状,加上述辅料,混合制成1000ml。The traditional Chinese medicine preparation of the present invention is obtained by extracting or processing the raw materials of traditional Chinese medicine composed of the above formula, taking 490g of Shanggangmei, 490g of iron-clad gold, 490g of rose apple, 196g of jasmine, and 490g of pandanus, and decocting them with water. The second time, 2 hours each time, the amount of water added each time is 6 times the amount of medicinal materials, the extracts are combined, filtered, the filtrate is concentrated into a thick paste, the above-mentioned auxiliary materials are added, and mixed to make 1000ml.

本发明的特殊之处在于对已有制备工艺进行了改进,将水煮改为水煮醇沉,工艺步骤为:取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加水煎煮二次,每次2小时,每次加水量为药材量的6倍,合并提取液,浓缩到相对密度为1.10~1.15(50~60℃),加95%的药用乙醇使溶液含醇量到60-70%,放置12-24小时,过滤,滤液浓缩,干燥,粉碎成细粉,加辅料,混合制成1000ml。The special feature of the present invention is that the existing preparation process has been improved, and water boiling is changed to water boiling and alcohol precipitation. The process steps are: take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus , add water and decoct twice, each time for 2 hours, the amount of water added each time is 6 times the amount of medicinal materials, the combined extracts are concentrated to a relative density of 1.10 to 1.15 (50 to 60 ° C), and 95% medicinal ethanol is added for use. The solution has an alcohol content of 60-70%, standing for 12-24 hours, filtering, concentrating the filtrate, drying, pulverizing into fine powder, adding auxiliary materials, and mixing to make 1000ml.

水提工艺提出的非药用成份较多,水提工艺含量差异性大且吸湿性大;会干扰了药品质量标准的检测,不能准确控制药品质量,工艺不稳定;水提醇沉工艺的样品鉴别项均能检出,有效成分含量较高,含量的差异性小,表明醇沉后的工艺稳定性好。There are many non-medicinal ingredients proposed by the water extraction process, the content of the water extraction process is highly variable and hygroscopic; it will interfere with the detection of drug quality standards, the quality of the drug cannot be accurately controlled, and the process is unstable; the samples of the water extraction and alcohol precipitation process All identification items can be detected, the content of active ingredients is high, and the difference in content is small, indicating that the process stability after alcohol precipitation is good.

本发明另一优选的改进是将水煮改为酒提,所述制备方法包括以下步骤:Another preferred improvement of the present invention is to change boiling to wine extraction, and the preparation method includes the following steps:

取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加95%乙醇回流提取二次,合并提取液,滤过,滤液浓缩至无醇味,得到稠膏状产物,加辅料混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose apple, stinky jasmine and pandanus, add 95% ethanol for reflux extraction twice, combine the extracts, filter, and concentrate the filtrate until it has no alcohol smell, and obtain a thick paste product. Add auxiliary materials and mix to make 1000ml.

本发明所述口服液有效的改善了不良口味,增加了病人服药顺应性。由于制剂处方口味优良,提高了产品的内在价值,这种制剂在同类产品竞争中会占据一定的优势,本发明的口服液适合各个年龄段的人群使用,尤其是在儿科用药时,口味易于小儿接受,增加临床使用范围。另外,本发明还有效的提高了口服液的澄清度,解决了中药口服液放置一段时间后容易产生沉淀的问题。The oral liquid of the invention can effectively improve the bad taste and increase the patient's medication compliance. Due to the excellent taste of the preparation prescription, which improves the intrinsic value of the product, this preparation will occupy a certain advantage in the competition of similar products. The oral liquid of the present invention is suitable for use by people of all ages, especially when it is used in pediatrics, the taste is easy for children. Accepted, increase the scope of clinical use. In addition, the invention also effectively improves the clarity of the oral liquid, and solves the problem that the traditional Chinese medicine oral liquid is prone to precipitation after being placed for a period of time.

本发明的口服液与现有技术相比较,还具有治疗效果好,副作用少,见效快,口感好,药品保质期长,稳定性好,成本低,制备工艺更加简单,节省了制备药物的时间等诸多优点。Compared with the prior art, the oral liquid of the present invention also has the advantages of good therapeutic effect, few side effects, quick effect, good taste, long drug shelf life, good stability, low cost, simpler preparation process, and saves time for preparing drugs, etc. Many advantages.

具体实施方式 Detailed ways

通过以下具体实施例对本发明作进一步说明,但不作为对本发明的限制。The present invention will be further illustrated by the following specific examples, but not as a limitation of the present invention.

实施例1、口服液Embodiment 1, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g

山梨酸钾2g      海藻酸钾3g    蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.

取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加水煎煮二次,每次24小时,每次加水量为药材量的6倍,合并提取液,浓缩,加95%的药用乙醇是溶液含醇量到70%,放置24小时,过滤,滤液浓缩,干燥,粉碎成细粉,加辅料,混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus, add water to decoct twice, 24 hours each time, add 6 times the amount of medicinal materials each time, combine the extracts, concentrate, add The 95% medicinal ethanol is that the solution contains 70% alcohol, put it aside for 24 hours, filter, concentrate the filtrate, dry, pulverize into fine powder, add auxiliary materials, and mix to make 1000ml.

实施例2、口服液Embodiment 2, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g

山梨酸钾2g      海藻酸钾3g    蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.

取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,用95%乙醇回流提取2次,第一次加10倍量,回流提取2小时,过滤,药渣第二次加8倍量,回流提取1小时,过滤,合并滤液,减压回收乙醇至无醇味,合并提取液,滤过,滤液浓缩至密度为1.15-1.20(60℃热测)稠膏状,加辅料混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus, and use 95% ethanol to reflux extract twice, add 10 times the amount for the first time, reflux extraction for 2 hours, filter, and dregs for the second time Add 8 times the amount, reflux extraction for 1 hour, filter, combine the filtrates, recover ethanol under reduced pressure until there is no alcohol smell, combine the extracts, filter, and concentrate the filtrate to a thick paste with a density of 1.15-1.20 (60°C thermal measurement), add The auxiliary materials are mixed to make 1000ml.

实施例3、综合疗效评价:Embodiment 3, comprehensive curative effect evaluation:

试验组:本发明实施例1,2的口服液;Test group: the oral liquid of embodiment 1 and 2 of the present invention;

现有颗粒剂对照组:石岐外感颗粒,中山市恒生药业有限公司生产,国药准字Z44020184。规格:每袋装10g,批号:20071201,Existing granule control group: Shiqi Waigan Granules, produced by Zhongshan Hengsheng Pharmaceutical Co., Ltd., Z44020184. Specifications: 10g per bag, batch number: 20071201,

方法:采用随机盲法、阳性药平行对照。METHODS: Random blind method and positive drug parallel control were adopted.

疗程:3天。Course of treatment: 3 days.

给药方案:(1)试验组:一次1瓶(10ml/瓶),一日3次;(2)对照组:一次2袋,一日3次。Dosing regimen: (1) Test group: 1 bottle (10ml/bottle) each time, 3 times a day; (2) Control group: 2 bags each time, 3 times a day.

试验结果如下:The test results are as follows:

综合疗效评定标准Comprehensive curative effect evaluation standard

痊愈:治疗3天以内体温恢复正常,感冒的症状和体征积分下降≥90%;Recovery: within 3 days of treatment, the body temperature returned to normal, and the symptoms and signs of colds decreased by ≥90%;

显效:治疗3天以内体温正常,感冒的症状和体征积分下降≥70%、<90%;Significantly effective: within 3 days of treatment, the body temperature is normal, and the symptoms and signs of colds are reduced by ≥70%, <90%;

有效:治疗3天以内体温较前降低,感冒症状和体征积分下降≥30%、<70%;Effective: within 3 days of treatment, the body temperature is lower than before, and the score of cold symptoms and signs is reduced by ≥30%, <70%;

无效:治疗3天以内体温未降或升高,感冒的症状和体征积分<30%。Ineffective: The body temperature did not drop or rise within 3 days of treatment, and the symptoms and signs of colds were less than 30%.

中医感冒风热证综合疗效评价:试验组(本发明实施例1)有效率90.17%;(本发明实施例2)有效率87.96%;现有颗粒剂对照组有效率85.21%。Comprehensive curative effect evaluation of TCM syndrome of cold and wind-heat: the effective rate of the test group (Example 1 of the present invention) is 90.17%; (Example 2 of the present invention) effective rate is 87.96%;

中医感冒暑湿证综合疗效评价:试验组(本发明实施例1)有效率91.45%;(本发明实施例2)有效率89.27%;现有颗粒剂对照组有效率83.17%。Comprehensive curative effect evaluation of TCM syndrome of common cold and heat-dampness: the effective rate of the test group (Example 1 of the present invention) is 91.45%; the effective rate of (Example 2 of the present invention) is 89.27%; the effective rate of the existing granule control group is 83.17%.

中医证候疗效判定标准Criteria for judging curative effect of TCM syndromes

疗效指数计算公式为(n)=(治疗前总积分-治疗后总积分)/治疗前总积分×100%(尼莫地平法)The formula for calculating curative effect index is (n)=(total score before treatment-total score after treatment)/total score before treatment×100% (nimodipine method)

临床痊愈:疗效指数(积分值降低)≥95%;Clinical recovery: curative effect index (integral value reduction) ≥ 95%;

显效:70%≤疗效指数(积分值降低)<95%;Markedly effective: 70% ≤ curative effect index (integral value reduction) < 95%;

有效:30%≤疗效指数(积分值降低)<70%;Effective: 30% ≤ curative effect index (integral value reduction) < 70%;

无效:疗效指数(积分值降低)<30%。Ineffective: curative effect index (decrease in integral value) <30%.

中医感冒风热证证候疗效评价:试验组(本发明实施例1)有效率89.45%;(本发明实施例2)有效率89.66%;现有颗粒剂对照组有效率87.37%。Evaluation of the curative effect of traditional Chinese medicine cold and wind-heat syndrome: the effective rate of the test group (the embodiment 1 of the present invention) is 89.45%; the effective rate of (the embodiment 2 of the present invention) is 89.66%;

中医感冒暑湿证证候疗效评价:试验组(本发明实施例1)有效率93.27%;(本发明实施例2)有效率89.22%;现有颗粒剂对照组有效率88.07%。Evaluation of the curative effect of TCM cold and heat-dampness syndrome: the effective rate of the test group (Example 1 of the present invention) is 93.27%; (Example 2 of the present invention) effective rate is 89.22%; the effective rate of the existing granule control group is 88.07%.

退热疗效判定标准Criteria for Judgment of Antipyretic Efficacy

痊愈:治疗24小时内,体温恢复正常,且无反复;Recovery: within 24 hours of treatment, the body temperature returned to normal without recurrence;

显效:治疗24小时内,体温降低≥1.0℃以上,但未至正常;Significantly effective: within 24 hours of treatment, the body temperature drops ≥ 1.0°C, but not to normal;

有效:治疗24小时内,体温降低>0.5<1.0℃,但未至正常;Effective: Within 24 hours of treatment, the body temperature decreased by >0.5<1.0°C, but not to normal;

无效:治疗24小时内,体温降低不足0.5℃。Ineffective: within 24 hours of treatment, the temperature drop is less than 0.5°C.

退热疗效(24小时)与退热起效时间比较Comparison of antipyretic efficacy (24 hours) and antipyretic onset time

风热感冒比较:试验组(本发明实施例1)退热疗效(24小时)有效率83.78%;(本发明实施例2)有效率78.28%;现有颗粒剂对照组有效率75.27%。Anemopyretic cold comparison: test group (the embodiment of the present invention 1) antipyretic curative effect (24 hours) effective rate 83.78%; (the present invention 2) effective rate 78.28%; Existing granule control group effective rate 75.27%.

暑湿感冒比较:试验组(本发明实施例1)退热疗效(24小时)有效率81.25%;(本发明实施例2)有效率80.52%,现有颗粒剂对照组有效率76.85%。Shushi cold comparison: test group (embodiment 1 of the present invention) antipyretic curative effect (24 hours) effective rate 81.25%; (embodiment 2 of the present invention) effective rate 80.52%, existing granule control group effective rate 76.85%.

单项症状疗效评价:Efficacy evaluation of individual symptoms:

头痛:试验组(本发明实施例1)有效率90.24%;(本发明实施例2)有效率88.56%,现有颗粒剂对照组有效率86.10%。Headache: the effective rate of the test group (Example 1 of the present invention) is 90.24%; the effective rate of (Example 2 of the present invention) is 88.56%, and the effective rate of the existing granule control group is 86.10%.

恶心:试验组(本发明实施例1)有效率96.25%;(本发明实施例2)有效率80.87%,现有颗粒剂对照组有效率89.38%。Nausea: the effective rate of the test group (Example 1 of the present invention) is 96.25%; the effective rate of (Example 2 of the present invention) is 80.87%, and the effective rate of the existing granule control group is 89.38%.

安全性评价:本发明实施例1的药物在治疗前后检查了血、尿、便常规、肝功能、肾功能和心电图,根据试验前后安全性指标检测结果,未发现新增实验室检查指标异常情况出现。Safety evaluation: The drug of Example 1 of the present invention has been checked for blood, urine, stool routine, liver function, kidney function and electrocardiogram before and after treatment. According to the test results of safety indicators before and after the test, no abnormalities in newly added laboratory inspection indicators were found. Appear.

实施例4、口服液Embodiment 4, oral liquid

岗梅245g        铁包金245g      蒲桃245gGangmei 245g Iron clad gold 245g Rose apple 245g

臭屎茉莉98g     露兜簕245g      蔗糖2gSmelly jasmine 98g Pandanus 245g Sucrose 2g

山梨酸钾1g      海藻酸钾1.5g    蒸馏水到1000ml。Potassium sorbate 1g Potassium alginate 1.5g Distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例5、口服液Embodiment 5, oral liquid

岗梅2980g        铁包金980g    蒲桃980gGangmei 2980g Iron clad gold 980g Rose apple 980g

臭屎茉莉392g     露兜簕980g    蔗糖100gStinking jasmine 392g Pandanus 980g Sucrose 100g

山梨酸钾4g       海藻酸钾6g    蒸馏水到1000ml。Potassium sorbate 4g Potassium alginate 6g Distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例12、口服液Embodiment 12, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    甜菊糖甙2.5gStinking jasmine 196g Pandanus 490g Stevioside 2.5g

苯酚1.5g        海藻酸钾4g    蒸馏水到1000ml。Phenol 1.5g Potassium alginate 4g Distilled water to 1000ml.

实施例6、口服液Embodiment 6, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    甜菊糖甙4gStinking jasmine 196g Pandanus 490g Stevioside 4g

苯酚2g          琼脂3g        蒸馏水到1000mlphenol 2g agar 3g distilled water to 1000ml

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例7、口服液Embodiment 7, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    木糖醇4gSmelly feces jasmine 196g Pandanus 490g Xylitol 4g

ZTC1+1 2g       琼脂3g        蒸馏水到1000ml。ZTC1+1 2g agar 3g distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例8、口服液Embodiment 8, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    木糖醇4gSmelly feces jasmine 196g Pandanus 490g Xylitol 4g

ZTC1+1 2g       糊精3g        蒸馏水到1000ml。ZTC1+1 2g dextrin 3g distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例9、口服液Embodiment 9, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    甜菊糖甙2gStinking jasmine 196g Pandanus 490g Stevioside 2g

壳聚糖1g        海藻酸钾1.5g  蒸馏水到1000ml。Chitosan 1g Potassium alginate 1.5g Distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例10、口服液Embodiment 10, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    甜菊糖甙8gStinking jasmine 196g Pandanus 490g Stevioside 8g

壳聚糖4g        海藻酸钾6g    蒸馏水到1000ml。Chitosan 4g Potassium alginate 6g Distilled water to 1000ml.

制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.

实施例11、口服液Embodiment 11, oral liquid

岗梅490g        铁包金490g    蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g

臭屎茉莉196g    露兜簕490g    甜菊糖甙6gStinking jasmine 196g Pandanus 490g Stevioside 6g

壳聚糖2g        海藻酸钾5g    蒸馏水到1000ml。Chitosan 2g Potassium alginate 5g Distilled water to 1000ml.

Claims (1)

1. stone qi diseases caused by exogenous pathogenic factor Chinese medicine oral liquid, be processed into by following raw material of Chinese medicine medicine and pharmaceutically acceptable carrier:
Flos Ilicis Asprellae 245-980g Radix berchemiae lineatae 245-980g Jambul 245-980g
Smelly dung jasmine 98-392g Pandanus tectorius (L.) Parkins. 245-980g sucrose 2-100g
Potassium sorbate 1-4g potassium alginate 1.5-6g distilled water 10-1000ml
The method for preparing step is following:
Get above five tastes Flos Ilicis Asprellae, Radix berchemiae lineatae, Jambul, smelly dung jasmine and Pandanus tectorius (L.) Parkins. add 95% alcohol reflux secondary, and merge extractive liquid, filters, and filtrating is concentrated into does not have the alcohol flavor, obtains thick paste shape product, adds adjuvant and is mixed and made into 1000ml.
CN201010547777A 2010-11-12 2010-11-12 A kind of Shiqi exogenous Chinese medicine oral liquid Expired - Fee Related CN101991723B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201010547777A CN101991723B (en) 2010-11-12 2010-11-12 A kind of Shiqi exogenous Chinese medicine oral liquid
HK11107207.1A HK1153132B (en) 2011-07-12 A kind of chinese medicinal oral liquid from shiqi against exogenous infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010547777A CN101991723B (en) 2010-11-12 2010-11-12 A kind of Shiqi exogenous Chinese medicine oral liquid

Publications (2)

Publication Number Publication Date
CN101991723A CN101991723A (en) 2011-03-30
CN101991723B true CN101991723B (en) 2012-09-05

Family

ID=43782799

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010547777A Expired - Fee Related CN101991723B (en) 2010-11-12 2010-11-12 A kind of Shiqi exogenous Chinese medicine oral liquid

Country Status (1)

Country Link
CN (1) CN101991723B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105879432A (en) * 2015-01-18 2016-08-24 广东省中医院 Method for clarifying Chinese herbal preparation for treating psoriasis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中华人民共和国卫生部药典委员会.石歧外感茶颗粒.《中华人民共和国卫生部药品标准中药成方制剂第十四册》.1997,26. *

Also Published As

Publication number Publication date
CN101991723A (en) 2011-03-30
HK1153132A1 (en) 2012-03-23

Similar Documents

Publication Publication Date Title
CN102188575B (en) Oral liquid preparation for treating infantile indigestion with food retention and cough and preparation method thereof
CN108310124B (en) A kind of oral liquid for clearing lung heat and preparation method thereof
CN101991723B (en) A kind of Shiqi exogenous Chinese medicine oral liquid
CN116941700B (en) Throat-clearing and throat-moistening candy rich in vitamin C and preparation method thereof
CN102772663A (en) Orally-taken medicine for preventing and treating infantile asthma and preparation method thereof
CN102178792B (en) Shiqi exogenous traditional Chinese medicine buccal tablet
CN107625828A (en) A kind of health protection tea for auxiliary treatment chronic pharyngitis, preparation method and application
CN104840737B (en) Chinese medicine composition with qi invigorating and lung moistening effect and its preparation method and application
CN102973657B (en) Cough-relieving Qinbaohong mixture and preparation method thereof
CN101983669B (en) Shiqi exogenous traditional Chinese medicine syrup
CN101991722B (en) Shiqi exogenous traditional Chinese medicine capsule
CN101711823B (en) Medicines used to treat asthmatic bronchitis
CN101983667B (en) A kind of traditional Chinese medicine drink with exogenous Shiqi
CN106913516A (en) A kind of blue syrup in Pu ground and its production and use
CN101991721A (en) A kind of sugar-free granule of Shiqi exogenous traditional Chinese medicine
CN110179855A (en) A kind of therapeutic agent and its formulation preparation method of post-natal depression
CN116211993B (en) Composition for treating senile chronic disease and its preparation method
CN103623203B (en) A kind of preparation method of dimethoxanate oral formulations
CN108030887A (en) A kind of Chinese materia medica syrup for being used to treat cough variant asthma in childhood: prednison comparing
CN107596107B (en) Heat-clearing, sore-throat-relieving and anti-allergic traditional Chinese medicine preparation and preparation method thereof
HK1153132B (en) A kind of chinese medicinal oral liquid from shiqi against exogenous infection
CN111870654A (en) Traditional Chinese medicine compound for preventing and treating recurrent respiratory tract infection of children
CN104840795A (en) Traditional Chinese medicine composition for treating infantile dry cough
CN115089689A (en) Traditional Chinese medicine composition for treating spasmodic cough and preparation method and application thereof
CN116870078A (en) Traditional Chinese medicine composition for treating influenza and method, composition particles and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1153132

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1153132

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120905

Termination date: 20171112